Search results
Results from the WOW.Com Content Network
Wojcicki, who controls 49.75% of voting rights at the company, has said she will not entertain outside bids to acquire 23andMe. In our call, she said she could not talk about the board crisis or ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private. In a Tuesday letter addressed to Wojcicki, the seven directors ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
For premium support please call: 800-290-4726 more ways to reach us
In March 2006 Avey, Anne Wojcicki, and Paul Cusenza founded 23andMe, [8] [9] [10] "one of the first, and only, [clarification needed] companies to offer genetic profiles directly to consumers, rather than through doctors or researchers". [11] Avey left the company in 2009. [12] Cusenza had left the company in 2007. [citation needed]